Ocrevus 300 mg concentrate for solution for infusion | medicines.ie

Company: Roche Registration GmbH
Active Ingredient: Ocrelizumab
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Date of revision: 10/2026

*further information is available on request to the holder of the authorisation or in the SPC

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/17/1231/001	300 milligram(s)	L04AA, L04AG08	Concentrate for solution for infusion

Licence number: EU/1/17/1231/001
Strength: 300 milligram(s)
ATC Code: L04AA, L04AG08
Dosage Form: Concentrate for solution for infusion

Roche Registration GmbH

3030 Lake Drive, Citywest Business Campus, Dublin 24, D24 KX6Y, Ireland

Email: ireland.druginfo@roche.com